HomeALZN • NASDAQ
add
Alzamend Neuro Inc
Previous close
$2.16
Day range
$2.10 - $2.26
Year range
$1.88 - $11.97
Market cap
8.33M USD
Avg Volume
82.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 998.11K | -26.51% |
Net income | -1.00M | 26.50% |
Net profit margin | — | — |
Earnings per share | -0.30 | 91.67% |
EBITDA | -970.42K | 27.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.45M | 8.71% |
Total assets | 5.09M | 1.68% |
Total liabilities | 717.49K | -42.82% |
Total equity | 4.37M | — |
Shares outstanding | 3.80M | — |
Price to book | 1.88 | — |
Return on assets | -43.71% | — |
Return on capital | -51.36% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -1.00M | 26.50% |
Cash from operations | -1.17M | 65.55% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.17M | -140.41% |
Free cash flow | -796.16K | 71.93% |
About
Founded
2016
Headquarters
Website
Employees
6
